Extended indication Imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first
Therapeutic value Possibly no place in the treatment regimen
Total cost 27,276,000.00
Registration phase Registered

Product

Registration

Therapeutic value

Expected patient volume per year

Expected cost per patient per year

Potential total cost per year

Off label use

Indication extension

Other information